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Abstract
Introduction: The degenerate intervertebral disc (IVD) becomes innervated by sensory nerve fibres, and vascularised
by blood vessels. This study aimed to identify neurotrophins, neuropeptides and angiogenic factors within native IVD
tissue and to further investigate whether pro-inflammatory cytokines are involved in the regulation of expression levels
within nucleus pulposus (NP) cells, nerve and endothelial cells.
Methods: Quantitative real-time PCR (qRT-PCR) was performed on 53 human IVDs from 52 individuals to investigate
native gene expression of neurotrophic factors and their receptors, neuropeptides and angiogenic factors. The
regulation of these factors by cytokines was investigated in NP cells in alginate culture, and nerve and endothelial cells
in monolayer using RT-PCR and substance P (SP) protein expression in interleukin-1 (IL-1β) stimulated NP cells.
Results: Initial investigation on uncultured NP cells identified expression of all neurotrophins by native NP cells, whilst
the nerve growth factor (NGF) receptor was only identified in severely degenerate and infiltrated discs, and brain
derived neurotrophic factor (BDNF) receptor expressed by more degenerate discs. BDNF expression was significantly
increased in infiltrated and degenerate samples. SP and vascular endothelial growth factor (VEGF) were higher in
infiltrated samples. In vitro stimulation by IL-1β induced NGF in NP cells. Neurotropin-3 was induced by tumour necrosis
factor alpha in human dermal microvascular endothelial cells (HDMECs). SP gene and protein expression was increased
in NP cells by IL-1β. Calcitonin gene related peptide was increased in SH-SY5Y cells upon cytokine stimulation. VEGF
was induced by IL-1β and interleukin-6 in NP cells, whilst pleiotrophin was decreased by IL-1β. VEGF and pleiotrophin
were expressed by SH-SY5Y cells, and VEGF by HDMECs, but were not modulated by cytokines.
Conclusions: The release of cytokines, in particular IL-1β during IVD degeneration, induced significant increases in NGF
and VEGF which could promote neuronal and vascular ingrowth. SP which is released into the matrix could potentially
up regulate the production of matrix degrading enzymes and also sensitise nerves, resulting in nociceptive transmission
and chronic low back pain. This suggests that IL-1β is a key regulatory cytokine, involved in the up regulation of factors
involved in innervation and vascularisation of tissues.
Introduction
The intervertebral disc (IVD) is considered the largest
aneural structure within the human body and is com-
posed of three main anatomical regions; the central nu-
cleus pulposus (NP), constrained by the annulus fibrosus
(AF) and the cartilaginous end plate. During degener-
ation, nociceptive nerves are seen to accompany blood
vessels into the IVD [1-3], yet the mechanisms of how
this occurs are unclear. Chronic low back pain is wide-
spread, affecting 80% of the population at some point in
their lives, with 40% of cases attributed to degeneration
of the IVD [4], costing the economy millions each year
[5]. The link between IVD degeneration and pain pro-
duction was traditionally thought to be due to compres-
sion of the nerve root, but links have been shown
between neural ingrowth and painful discs [6], leading
to new ideologies emerging [7,8]. IVD degeneration is
characterised by the loss of extracellular matrix and
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altered biomechanical properties caused by an imbalance
between anabolic and catabolic factors [9,10]. Cytokines
such as interleukin-1 (IL-1β) and tumour necrosis factor
alpha (TNFα) are known for their role within IVD de-
generation and herniation [11-18] and lead to the upreg-
ulation of matrix-degrading enzymes, mainly matrix
metalloproteinases MMP-3 and MMP-13 and a disinte-
grin and metalloproteinase with thrombospondin motifs
ADAMTS-1, ADAMTS-4 and DAMTS-5 [18-24], which
cleave both aggrecan and collagen type II. Infiltration of
blood vessels and nerve fibres is considered a character-
istic feature of IVD degeneration [25] and is associated
with increased pain sensation.
Current literature surrounding the mechanisms of low
back pain associated with neural ingrowth have concen-
trated on factors that promote ingrowth and survival of
nerves, such as the neurotrophic factors, nerve growth
factor (NGF), brain-derived neurotrophic factor (BDNF)
and neurotrophin-3 (NT3), along with their receptors,
the tropomyosin kinases TrkA, TrkB and TrkC [26-31].
Freemont and colleagues was the first group to identify
the nonmyelinated nerve fibres in IVDs associated with
pain, which were also shown to express Substance P
(SP) [1]. The same group later identified that these nerve
fibres expressed TrkA and accompanied microvessels
into the degenerate IVD that expressed NGF [6]. Abe
and colleagues found that human NP cells constitutively
express NGF and BDNF, yet expression increases in re-
sponse to IL-1β and TNFα [32]. TNFα also induced SP
mRNA expression from IVD cells [30], implicating a role
in neoinnervation of the degenerate IVD. Nerve in-
growth is often seen to follow the track of ingrowing
blood vessels, with neurotrophic factors expressed by
blood vessels proposed to drive the neuronal ingrowth
[6]. Angiogenic factors include pleiotrophin and vascular
endothelial cell growth factor (VEGF), which have been
shown to be produced by human IVD cells, with in-
creased expression seen in discs with higher numbers of
blood vessels [33,34]. However, whether the expression
of these factors alters during degeneration has not been
investigated to date, and limited studies have investi-
gated their regulation by cytokines.
This study aimed to identify a wide range of neuro-
trophic factors along with their receptors, pain-related
peptides and angiogenic factors at the mRNA level from
RNA directly extracted from degenerate human NP tis-
sue, and to further investigate whether proinflammatory
cytokines are involved in the regulation of their expres-
sion in human NP, nerve and endothelial cells.
Materials and methods
Human tissue
Human IVD tissue was obtained from surgery or post-
mortem examination with informed consent of the patient
or relatives. Ethical approval was obtained from Sheffield
Research Ethics Committee (09/H1308/70). Details of all
patient samples are presented in Table 1. IVD tissue
was obtained from 51 patients undergoing microdiscect-
omy for nerve root compression, cauda equine syn-
drome or sciatica and from two postmortem samples
from one individual.
Tissue processing
Tissue consisting of AF and NP was fixed in 10% neutral
buffered formalin, and processed to paraffin wax. Fol-
lowing embedding, 4 μm tissue sections were taken for
haematoxylin and eosin staining, and stained sections
were evaluated independently by two researchers (ALAB
and CLLM) to determine the extent of degenerative tis-
sue changes. Sections were scored numerically between
0 and 12 based on the presence of cell clusters, fissures,
loss of demarcation and haematoxophilia (indicating
reduced proteoglycan content); a score of 0 to 3 indi-
cates a histologically normal (nondegenerate) IVD and a
grade ≥4 indicates evidence of degeneration, as described
previously [18,35]. Interobserver scores were averaged and
assigned to each tissue sample. Sections were also taken
for routine immunohistochemical analysis of CD11b
expression. CD11b is a leukocyte adhesion molecule and
was used to identify immune cell infiltrates in NP tissue
samples from prolapsed IVDs. CD11b immunohistochem-
ical analysis was performed as described previously [35].
Samples were classified as infiltrated on the basis of
CD11b immunopositivity. On account of the heterogen-
eity often observed in prolapsed IVD tissues [36], serial
sections were made from paraffin-embedded tissues that
had matched cDNA samples derived from surgically ob-
tained NP. Routine histological and immunohistochemical
examinations were made on multiple sections, at different
levels throughout the paraffin-embedded tissue, to ensure
assessment of any heterogeneity. cDNA samples were only
considered to be from nondegenerate tissue if all haema-
toxylin and eosin-stained sections were assigned a histo-
logical grade of degeneration <4. cDNA samples were
considered to be from an infiltrated IVD if CD11b immu-
nopositivity (indicating leukocyte presence) was observed
in any tissue section evaluated.
Native nucleus pulposus cell extraction and investigations
of native neurotrophic and angiogenic factor expression
Isolation of disc cells
Samples from degenerate IVD tissue were obtained from
51 patients undergoing microdiscectomy for the treatment
of low back pain and from two postmortem samples from
one individual. NP tissue was separated from contamina-
ting AF and end plate and digested with 2 U/ml protease
(Sigma, Poole, UK) in Dulbecco’s modified Eagle’s media
for 30 minutes at 37°C, and washed twice with Dulbecco’s
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Table 1 Patient details of NP cells used within this study
Code Source Age IVD level IVD intact Average grade Infiltrated
1 Surgical 32 L5/S1 Yes 2.0
2 Postmortem 45 L4/L5 Yes 2.0
3 Postmortem 45 L3/L4 Yes 3.0
4 Surgical 51 L4/L5 2.0
5 Surgical 42 L5/S1 Yes 3.0
6 Surgical 24 L4/L5 No 3.0
7 Surgical 38 L5/S1 No 3.5
8 Surgical 25 L4/L5 Yes 4.0
9 Surgical 45 L5/S1 Yes 4.0
10 Surgical 43 L5/S1 No 4.0
11 Surgical 47 L5/S1 Yes 5.3
12 Surgical 47 L5/S1 Yes 5.85
13 Surgical 26 C3/C5 6.0
14 Surgical 30 L5/S1 No 6.15
15 Surgical 46 L5/S1 No 6.16
16 Surgical 70 C5/C6 6.18
17 Surgical 65 L3/L4 No 6.5
18 Surgical 52 L4/L5 No 6.7
19 Surgical 66 L5/S1 Yes 6.85
20 Surgical 43 L5/S1 No 7.0
21 Surgical 44 L5/S1 Yes 7.0
22 Surgical 38 L5/S1 7.0
23 Surgical 36 L5/S1 Yes 8.0
24 Surgical 28 L5/S1 No 8.0
25 Surgical 35 L5/S1 Yes 8.0
26 Surgical 33 L4/L5 Yes 8.0
27 Surgical 37 L5/S1 Yes 8.0
28 Surgical 49 L4/L5 No 8.0
29 Surgical 29 L5/S1 No 8.0
30 Surgical 42 L4/L5 No 8.0
31 Surgical 38 L4/L5 No 8.15
32 Surgical 42 L5/S1 No 9.0
33 Surgical 38 C6/C7 No 9.0
34 Surgical 48 L4/L5 No 10.0
35 Surgical 26 L5/S1 No 11.0
36 Surgical 35 L4/L5 No 11.0
37 Surgical 49 L2/L3 No 1.0 Yes
38 Surgical 20 L4/L5 No 3.0 Yes
39 Surgical 40 L5/S1 No 3.0 Yes
40 Surgical 39 L4/L5 No 3.0 Yes
41 Surgical 42 L4/L5 No 4.0 Yes
42 Surgical 26 L4/L5 Yes 4.0 Yes
43 Surgical 31 L5/S1 No 4.0 Yes
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modified Eagle’s media. Following this, NP cells were iso-
lated using 2 mg/ml collagenase type 1 (Sigma Aldrich)
for 4 hours at 37°C. Cells were passed through a 40 μm
cell strainer (Sigma Aldrich, Paisley, UK) as published pre-
viously [37]. Following extraction, cells were used for ei-
ther direct RNA extraction or cell culture.
Quantitative real-time polymerase chain reaction on directly
extracted RNA from human nucleus pulposus cells
Quantitative real-time polymerase chain reaction (qRT-
PCR) was conducted on nine nondegenerate samples
(grade 0 to 3) from eight patients, 12 moderately degen-
erate samples (grade 4 to <7) from 12 patients, and 19
severely degenerate samples (grade 7 to 12) from 19 pa-
tients, and 13 samples with evident infiltration from pa-
tients experiencing pain (Table 1). Extracted RNA was
subjected to treatment with DNase (Qiagen, Manchester,
UK) and purified using the Qiagen MinElute Cleanup kit
prior to cDNA synthesis using Bioscript RT enzyme
(Bioline, London, UK) and random hexamers (Applied
Biosystems, Paisley, UK) [37].
qRT-PCR was performed on a StepOnePlus™ Real-Time
PCR System (Applied Biosystems) in order to investigate
gene expression levels of neurotrophic factors NGF, BDNF
and NT3 and their receptors TrkA, TrkB and TrkC, along
with pain-related peptides SP and calcitonin gene-related
peptide (CGRP) and angiogenic factors VEGF and
pleiotrophin (Applied Biosystems) within directly ex-
tracted samples from degenerate and nondegenerate
samples. Glyceraldehyde-3-phosphate dehydrogenase and
18S (Applied Biosystems) were used as housekeeping
genes to allow normalisation. Ten-microlitre reactions
were prepared using the TaqMan Universal PCR Master
Mix (Applied Biosystems). Results were analysed using
the 2–ΔCt method and presented as relative gene
expression normalised to the average cycle threshold for
the two housekeeping genes.
Cytokine regulation of neurotrophic factors, angiogenic
factors and pain peptides in human nucleus pulposus
cells, SH-SY5Y cells and human dermal microvascular
endothelial cells
Monolayer nucleus pulposus cell culture
Following extraction, NP cells were plated out into culture
flasks for expansion in monolayers, and were cultured in
Dulbecco’s modified Eagle’s media supplemented with 10%
v/v heat-inactivated foetal calf serum, 100 U/ml penicillin,
100 μg/ml streptomycin, 250 ng/ml amphotericin, 2 mM
glutamine (Invitrogen) and 50 μg/ml ascorbic acid (Sigma
Aldrich) (Complete cell culture media) and maintained at
37°C in a humidified atmosphere containing 5% carbon
dioxide. Complete culture media was changed every 3 days.
Alginate culture
To redifferentiate NP cells towards their native phenotype,
cells were cultured in alginate beads that have been shown
previously to maintain NP phenotype [18]. Alginate culture
also enables RNA extraction and gene expression analysis
because cells can be released easily from three-dimensional
culture for analysis. Following expansion in monolayers up
to passage 2, NP cells were suspended in 1.2% medium vis-
cosity sodium alginate (Sigma Aldrich) at 4 × 106 cells/ml
and alginate beads formed via dropping through a 19-gauge
needle into 200 mM CaCl2 (Sigma Aldrich). After incuba-
tion at 37 °C for 10 minutes, beads were washed twice with
0.15 M NaCl (Sigma Aldrich) before being washed twice in
complete media. All NP cells used in this experiment were
cultured in alginate for 2 weeks prior to cytokine treatment
to enable the cells to regain native cellular phenotypes [38].
Table 1 Patient details of NP cells used within this study (Continued)
44 Surgical 39 L5/S1 No 5.0 Yes
45 Surgical 62 L3/L4 Yes 6.0 Yes
46 Surgical 40 L5/S1 Yes 7.0 Yes
47 Surgical 33 L5/S1 Yes 9.0 Yes
48 Surgical 45 L4/L5 No 3.0
49 Surgical 27 L5/S1 No 3.0
50 Surgical 21 L5/S1 No 7.0 Yes
51 Surgical 38 L4/L5 No 7.0 Yes
52 Surgical L5/S1 No 8.0
53 Surgical 28 L4/L5 Yes 9.0
Eight patient samples were classified as nondegenerate (grade 0 to 3), 12 patient samples were classed as moderately degenerate (grade 4 to 6), 20 IVD samples
were classified as severely degenerate (grade 7 to 12) and 12 patients had evidence of infiltration. Note, samples 2 and 3 are from the same postmortem
individual. Patients in bold were used in cytokine treatment experiments. Samples 48, 50, 51, 52 and 53 were used for interleukin-1β treatments. Samples 49, 51
and 52 were used in interleukin-6 and tumour necrosis factor alpha treatments. NP, nucleus pulposus; IVD, intervertebral disc.
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Monolayer SH-SY5Y and human dermal microvascular
endothelial cell culture
SH-SY5Y neuroblastoma cells were differentiated by a
7-day pretreatment with 5 μM retinoic acid prior to seed-
ing into a six-well plate at a cell density of 5 × 105 cells/ml.
Human dermal microvascular endothelial cells (HDMEC)
were seeded into six-well plates at a density of 1 × 106
cells/ml in complete HDMEC growth factor media (Pro-
moCell, Heidelberg, Germany, UK).
Cytokine treatments
Human nucleus pulposus cell cytokine treatments
Following 2-week culture in alginate beads, NP cells
were treated with proinflammatory cytokines known to
be upregulated during IVD degeneration and herniation,
including IL-1β, IL-6 and TNFα (Peprotech, London
UK) for 48 hours. NP cells were treated with IL-6 and
TNFα at 0, 1, 10 and 100 ng/ml in serum-free media in
triplicate for three independent patients (Table 1). IL-1β
treatments were performed for five patients (Table 1) in
triplicate (0, 1, 10, 100 ng/ml) and for three patients
(Table 1) in triplicate at a wider concentration range (0,
0.001, 0.01, 0.1, 1, 10 and 100 ng/ml) for 48 hours to
identify dose responses. Conditioned media were col-
lected after 48 hours and used for further analysis.
SH-SY5Y and HDMEC cytokine treatments
SH-SY5Y and HDMEC cells were allowed to adhere for
24 hours prior to stimulation with 10 ng/ml IL-1β, IL-6,
IL-8 or TNFα for 48 hours.
RNA extraction and cDNA synthesis
Following cytokine treatments, triplicate alginate beads
were used for the analysis of a number of neurotrophic
factors and their receptors, pain-related peptides and an-
giogenic factors. RNA was extracted using TRIzol re-
agent (Gibco, Paisley, UK). Prior to TRIzol extraction,
alginate beads were washed in 0.15 M NaCl and dis-
solved by application of alginate dissolving buffer (55
mM sodium citrate (Na3C6H5O7), 30 mM Na ethylene-
diamine tetraacetic acid and 0.15 M NaCl at pH 6.8) for
15 minutes at 37°C followed by digestion of extracellular
matrix in 0.06% w/v collagenase type 1 (Sigma) for 30
minutes.
Extracted RNA was subjected to treatment with DNase
(Qiagen) and purified using the Qiagen MinElute Cleanup
kit prior to cDNA synthesis using Bioscript RT enzyme
(Bioline) and random hexamers (Applied Biosystems)
[37]. Target genes were investigated using qRT-PCR.
Real-time polymerase chain reaction
qRT-PCR was performed as described previously to investi-
gate gene expression levels of predesigned assays for neuro-
trophic factors NGF, BDNF and NT3 and their receptors
TrkA, rkB and TrkC, along with pain-related peptides SP
and CGRP and angiogenic factors VEGF and pleiotrophin
(Applied Biosystems). The qRT-PCR data were analysed
using the 2–ΔΔCt method where treatments were compared
with untreated controls as published previously [39].
Statistical analysis
qRT-PCR expression data were found to be nonparamet-
ric in distribution so the Kruskall–Wallis with Conover–
Inman post hoc analysis test was used to identify signifi-
cant differences between treatments (P ≤ 0.05).
Substance P enzyme-linked immunosorbent assay
Human SP peptide was identified in cell culture media from
IL-1β-stimulated NP cells. Human NP cells were cultured
in alginate beads as described previously and were stimu-
lated with 1, 10 or 100 ng/ml for 48 hours, after which con-
ditioned media was collected and SP levels were analysed
using a SP colourimetric enzyme linked immunosorbent
assay kit as per the manufacturer’s instructions (ab133029;
Abcam, Cambridge, UK). Data analysis was conducted
using the Kruskall–Wallis with Conover–Inman post hoc
analysis to identify significant differences between treat-
ments (P ≤ 0.05).
Results
Identification of neurotrophic factors and their receptors
within native IVD tissue
Directly extracted NP cells were investigated by qRT-PCR
for the native expression of neurotrophic factors and their
receptors, all of which were identified at the mRNA level
irrespective of their classification. NGF demonstrated con-
stitutive expression and was present in 100% of nondegener-
ate and degenerate samples, and in 92% of infiltrated
samples (Figure 1A). NGF receptor TrkA was expressed in
0% of nondegenerate (grade 0 to 3) samples, yet expression
increased to 10% in severely degenerate samples (grade 7
to 12) and to 17% in samples with the presence of infiltrat-
ing cells (Figure 1B). Similarly, BDNF receptor TrkB was
expressed in 50% of nondegenerate samples, increasing
to 92% expression in moderately (grade 4 to 6) and severely
degenerate samples and to 92% in infiltrated samples
(Figure 1D). BDNF expression was also present in 50%
of nondegenerate samples (Figure 1C), with percentage
expression increasing to 85% and 83% within the severely
degenerate and the infiltrated cohorts respectively. The
levels of expression within the infiltrated cohort were signifi-
cantly higher compared with the nondegenerate group
(P= 0.0471). Expression levels within the infiltrated cohort
were significantly higher than for both the moderately de-
generate group (P = 0.0058) and the severely degenerate
group (P < 0.0001). The number of samples expressing
BDNF also increased within the severely degenerate and the
infiltrated groups, as opposed to the nondegenerate group
LA Binch et al. Arthritis Research & Therapy 2014, 16:416 Page 5 of 15
http://arthritis-research.com/content/16/4/416
Figure 1 Identification of neurotrophic factors and their receptors within native intervertebral disc tissue. Percentage expression is
represented as the number of disc samples in each cohort that expressed the target gene, shown by the number above the bars. Bars
represent the levels of mRNA expression seen in these samples. Expression of neurotrophic nerve growth factor (NGF) (A) and its receptor
tropomyosin kinase (Trk)A (B), of brain-derived neurotrophic factor (BDNF) (C) and its receptor TrkB (D), and of neurotrophin 3 (NT3) (E) and its
receptor TrkC (F) in human intervertebral discs graded histologically: grade 0 to 3, n = 8; grade 4 to 6, n = 12; grade 7 to 12, n = 20; infiltrated,
n = 12 samples of intervertebral disc tissue. *Statistical significance between levels of gene expression: P≤ 0.05. GAPDH, glyceraldehyde-3-phosphate
dehydrogenase.
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(Figure 1C). NT3 was expressed in 75% of nondegenerate
samples, yet expression increased to 100% within degenerate
and infiltrated disease groups (Figure 1E). Conversely, NT3
receptor TrkC was expressed in very few samples in each
cohort, with no expression evident within the nondegener-
ate group, and only 33% and 40% of degenerate disc samples
displaying TrkC gene expression (Figure 1F).
Pain-related peptide expression in native IVD tissue
Native NP cells expressed neuropeptides in all disease
groups (Figures 2A and 2B). SP was expressed by 50% of
nondegenerate samples, increasing to 100% expression
within the severely degenerate group (Figure 2A). Ex-
pression levels of SP was significantly higher in the se-
verely degenerate cohort compared with those with
evidence of infiltration (P = 0.0235). CGRP was present
in 88% of nondegenerate samples (Figure 2B) and ex-
pression increased to 100% within both the degenerate
and infiltrated samples, although the mean level of ex-
pression is lower in these groups compared with the
nondegenerate samples (Figure 2B).
Angiogenic factors within native IVD tissue
Angiogenic factors VEGF and pleiotrophin were investi-
gated for their presence within native NP tissue at the
mRNA level. VEGF was constitutively expressed in 100%
of patient samples irrespective of disease classification
(Figure 2C). Interestingly, the levels of expression in non-
degenerate samples was significantly higher than the
severely degenerate cohorts (P = 0.0103). Additionally, ex-
pression levels of VEGF seen within the severely degener-
ate group were significantly higher than the level of
expression by infiltrated samples (P = 0.028). Pleiotrophin
(Figure 2D) was expressed by 38% of nondegenerate sam-
ples, rising to 75% in moderately degenerate and 60% in se-
verely degenerate samples, yet no significance was reached.
Figure 2 Neuropeptide and angiogenic factor expression within native intervertebral disc tissue. Percentage expression is represented as
the number of disc samples in each cohort that expressed the target gene, shown by the number above the bars. Bars represent the levels of
mRNA expression seen in these samples. Expression of pain-related peptides substance P (A) and calcitonin gene-related peptide (CGRP) (B) and
angiogenic factors vascular endothelial growth factor (VEGF) (C) and pleiotrophin (D) in human intervertebral discs graded histologically: grade 0
to 3, n = 8; grade 4 to 6, n = 12; grade 7 to 12, n = 20; infiltrated, n = 12. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. *Statistical
significance: P≤ 0.05.
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Neurotrophic factor regulation by cytokines
Following the identification of neurotrophic factor ex-
pression in native NP tissue, NP cells derived from de-
generate IVDs were cultured and stimulated with
proinflammatory cytokines to determine modulation by
inflammatory cytokines expressed during IVD degener-
ation. Following IL-1β treatment for 48 hours, human
NP cells significantly up regulated their expression of
neurotrophic factor NGF at concentrations ≥0.1 ng/ml
(P < 0.001) (Figure 3A), suggesting that IL-1β may be in-
volved in the regulation of neurotrophic factor produc-
tion from NP cells. Treatment with IL-6 and TNFα,
however, failed to significantly regulate neurotrophic fac-
tor production (Figure 3B,C), although a small nonsig-
nificant increase was seen following 100 ng/ml TNFα
(Figure 3B) and 10 and 100 ng/ml IL-6 (Figure 3C). IL-
1β treatment did not have an effect on BDNF or NT3
expression (Figure 3A), whilst small nonsignificant in-
creases in BDNF and NT3 were seen following TNFα
(Figure 3B) and IL-6 (Figure 3C).
Neurotrophic factor expression within SH-SY5Y cells
was not significantly altered following cytokine treat-
ment at 10 ng/ml for 48 hours (Figure 3D). NT3 was
significantly upregulated by 10 ng/ml TNFα (P ≤ 0.05)
stimulation in HDMEC compared with untreated con-
trols (Figure 3E), whereas BDNF was not expressed by
HDMEC (Figure 3E). IL-8 stimulation at 10 ng/ml
caused an increase in expression of NT3 in HDMEC, yet
this failed to reach significance (Figure 3E).
Neuropeptide regulation by cytokines
Neuropeptide expression following cytokine stimulation
was investigated by qRT-PCR. SP expression by human
NP cells (Figure 4A1,A2) was significantly increased
100-fold in response to 1 ng/ml IL-1β treatment for 48
hours. Higher doses of IL-1β caused similar effects on
SP expression (Figure 4A1). Lower concentrations of IL-
1β (1,10 and 100 pg/ml) were tested on three patient
samples in triplicate (data not shown) and interestingly
even 1 pg/ml IL-1β stimulation for 48 hours resulted in
significant upregulation of SP (P < 0.0001) compared
with controls. Conditioned media collected from IL-1β-
treated NP cells demonstrated 400 pg/ml SP protein
after 10 ng/ml IL-1β treatment for 48 hours (Figure 4A2),
which was significantly increased from 150 pg/ml in un-
treated NP cells (Figure 4A2). TNFα and IL-6 treatments
on human NP cells induced SP expression at doses ≥10
ng/ml (Figure 4B,C) yet this failed to reach significance.
CGRP expression was not significantly regulated by
cytokine treatments (Figure 4A1,B,C). SP and CGRP ex-
pression was not regulated by cytokine stimulation
within SH-SY5Y cells (Figure 4D), and SP was not
expressed by HDMEC cells (Figure 4E).
Angiogenic factor regulation by cytokines
VEGF and pleiotrophin were both significantly regulated
by IL-1β (Figure 5A). VEGF was upregulated 10-fold
(P < 0.001) in response to 1 to 10 ng/ml IL-1β treatment.
Pleiotrophin, however, was downregulated 50-fold (P < 0.001)
following 100 ng/ml IL-1β treatment. Pleiotrophin was also
downregulated by TNFα (Figure 5B) and IL-6 (Figure 5C)
in NP cells. IL-6 treatment at 10 and 100 ng/ml caused a
significant increase in VEGF expression in human NP cells,
yet pleiotrophin expression was not regulated by IL-6 in
NP cells (Figure 5C).
No significant changes in expression levels of VEGF and
pleiotrophin were observed in SH-SY5Y and HDMEC
when compared with untreated controls (Figure 5D,E).
Discussion
This study aimed to identify a number of factors in-
volved in innervation and vascularisation of the human
IVD during degeneration. Neurotrophins and their re-
ceptors, angiogenic factors and neuropeptides were posi-
tively identified at the mRNA level within a wide range
of NP samples from histologically graded nondegenerate
and degenerate IVDs. Further to this, proinflammatory
cytokines known to be upregulated within IVD degener-
ation [12,13,17,18,21,35,40,41], particularly IL-1β, were
shown to regulate such factors, leading to the hypothesis
that NP cells may be responsible for promoting innerv-
ation and vascularisation.
During disc degeneration and herniation, nerve and
blood vessels ingrow into deep layers of the IVD, which
are thought to contribute to the painful phenotype of the
degenerate IVD consequently leading to chronic low back
pain [6,42-46]. Early studies identified NGF-expressing
blood vessels accompanying sensory nerve fibres into the
inner AF and NP [6], which produce neurotransmitters in-
volved in pain transmission within the peripheral and cen-
tral nervous systems [47]. However, to date limited studies
have shown ingrowth into the NP tissue, and those which
do demonstrate the track for this is normally via the end-
plates rather than through the full thickness of the AF.
Blood vessels have been shown to track along annular fis-
sures, which could provide deeper access to the NP [48].
In addition, blood vessels have been shown to extensively
infiltrate into herniated NP material [33], which is thought
at least in part to be involved in the resorption of herni-
ated NP [33]. However, there is an urgent need for further
investigation into the presence, localisation and extent of
nerve and blood vessels during disc degeneration. This
study identified the presence of neurotrophic factors NGF,
BDNF and NT3 alongside their receptors TrkA, TrkB and
TrkC, pain-related peptides SP and CGRP and angiogenic
factors VEGF and pleiotrophin within native IVD tissue,
and found their expression to be modulated by cytokines.
Krock and colleagues demonstrated recently NGF and
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Figure 3 Cytokine regulation of neurotrophic factors NGF, BDNF and NT3 in human nucleus pulposus cells, SH-SY5Y cells and HDMEC cells.
Neurotrophic factor mRNA expression in human nucleus pulposus (NP) cells stimulated by interleukin (IL)-1 (A), tumour necrosis factor alpha (TNFα)
(B) and IL-6 (C). Neurotrophic factor mRNA expression in SH-SY5Y neuronal cells following cytokine stimulation (D). Neurotrophic factor mRNA
expression in human dermal microvascular endothelial cells (HDMEC; endothelial cell line) following cytokine stimulation (E). *Statistical significance:
P≤ 0.05. BDNF, brain-derived neurotrophic factor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NGF, nerve growth factor; NT3, neurotrophin 3.
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Figure 4 (See legend on next page.)
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BDNF protein production by IVD organ cultures from de-
generate disc were significantly higher than those from
healthy discs [49]. In the current study, all discs displayed
mRNA expression for NGF; however, previous studies
have found increased levels of NGF expression in surgical
degenerate IVD compared with postmortem tissues
[27,50]. The current study only included two postmortem
tissues so it was not possible to separate these data, which
could explain the lack of correlation seen in the current
study. However Purmessur and colleagues also found
high levels of NGF and BDNF within IVDs, with no sig-
nificant changes between regions of the IVD and disease
severity [30], which agrees with mRNA expression of
NGF shown in the current study. BDNF gene expression
in our current study, however, was seen at significantly
higher levels in degenerate and infiltrating discs and in
more degenerate samples than nondegenerate samples,
which confirms the recent results of Krock and col-
leagues suggesting these neurotrophic factors are in-
creased within degenerate discs [49].
Nerve ingrowth is mostly seen in moderately and se-
verely degenerate discs, and so it may have been pre-
sumed that NGF expression would have been increased
in these disease groups at the mRNA level. We have
shown constitutive expression of NGF within 100% of
IVD samples tested, although as the majority of the sam-
ples are from diseased tissues this is perhaps not surpris-
ing. Richardson and colleagues demonstrated that the
neurite outgrowth induced by NP cells derived from de-
generate discs was inhibited in the presence of an NGF
inhibitor [29], demonstrating the clear role for NP cell-
derived NGF in neurite outgrowth. Interestingly, TrkA,
the high-affinity receptor for NGF, was only expressed in
severely degenerate and infiltrated discs, suggesting that
NGF expressed by native NP cells is inactive in nonde-
generate samples, and during degeneration NGF is able
to signal a response through its receptor TrkA in an
autocrine manner. TrkA has also been shown in cultured
NP cells following isolation from degenerate IVDs and
could be induced by culture in neural differentiation
media [51], suggesting maintenance of NGF sensitivity in
culture. BDNF mRNA expression levels were significantly
higher within the degenerate and infiltrated groups as op-
posed to the nondegenerate cohort; likewise NGF receptor
TrkB was also up regulated in degenerate and infiltrated
groups, suggesting increased responsiveness to BDNF
within degeneration. Within the current study the major-
ity of degenerate discs displayed TrkB gene expression.
Navone and colleagues also demonstrated TrkB protein in
cultured NP cells, which was significantly increased by
culture in neural differentiation media [51]. The expres-
sion of neurotrophic factor receptors by native NP cells
raises the question of what effects the neurotrophins play
on NP cells. Articular chondrocytes were also shown re-
cently to express the TrkA receptor, and NGF stimulation
of a chondrocyte cell line prevented cellular differenti-
ation, suggesting a direct role in chondrocytic cell matur-
ation [52]. Further work is necessary to further elucidate
the role of NGF on NP cells and articular chondrocytes.
Peptide containing nerve fibres were first identified
within the IVD by Freemont and colleagues [1], who
demonstrated SP-expressing nerve fibres within deep tis-
sue of pain-level discs. SP and CGRP are neuropeptides
found within dorsal root ganglia neurons and C-fibres of
sensory neurons, ultimately involved in the facilitation of
pain perception within the peripheral and central ner-
vous system. In addition, CGRP has been shown to in-
duce proliferation of endothelial cells [53], suggesting
that expression by NP cells could also induce the angio-
genesis seen in disc degeneration. Here, we demonstrate
that SP is produced by NP cells and was seen in more
degenerate samples than nondegenerate NP samples,
with levels increasing in infiltrated discs compared with
degenerate discs. Similarly, Richardson and colleagues
demonstrated increased SP gene expression in surgical
degenerate discs compared with PM discs [50]; these
studies suggest that SP is increased during degeneration,
which could lead to increased pain sensation within in-
growing nerves.
Following the identification of neurotophic and angio-
genic factors within degenerate IVDs, the regulation of
these factors by key cytokines that have been shown previ-
ously to be upregulated during IVD degeneration was in-
vestigated to determine the regulation of neurotrophic
and angiogenic factors by potential responsive cells within
the disc. Cytokines have been widely studied in IVD de-
generation and are known to stimulate the production of
catabolic enzymes, consequently leading to the loss of
matrix molecules, particularly aggrecan and collagen type
II [18,54], which are essential for maintaining the IVD.
The early loss of aggrecan is a characteristic feature of
IVD degeneration, and the hypothesis is that this loss
(See figure on previous page.)
Figure 4 Cytokine regulation of neuropeptides substance P and CGRP within human nucleus pulposus cells, SH-SY5Y and HDMEC cells.
Substance P (SP) and calcitonin gene-related peptide (CGRP) mRNA expression in human nucleus pulposus (NP) cells following stimulation with interleukin
(IL)-1β (A1), tumour necrosis factor alpha (TNFα) (B) and IL-6 (C). SP protein was also determined in human NP cells following stimulation with IL-1β
(A2). SP and CGRP mRNA expression in SH-SY5Y neuronal cells following cytokine stimulation (D). SP mRNA was not expressed by human dermal
microvascular endothelial cells (HDMEC)-1 and cytokines did not significantly regulate CGRP mRNA expression (E). *Statistical significance: P≤ 0.05.
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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Figure 5 Cytokine regulation of angiogenic factors VEGF and pleiotrophin in human nucleus pulposus cells, SH-SY5Y and HDMEC cells.
Vascular endothelial growth factor (VEGF) and pleiotrophin mRNA expression in human nucleus pulposus (NP) cells following stimulation with
interleukin (IL)-1β (A), tumour necrosis factor alpha (TNFα) (B) and IL-6 (C). VEGF and pleiotrophin mRNA expression in human NP cells following
cytokine stimulation (D). Human dermal microvascular endothelial cells (HDMEC) cells did not express pleiotrophin mRNA, and cytokines
nonsignificantly upregulated VEGF mRNA expression (E). *Statistical significance: P≤ 0.05. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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could in fact lead to the unopposed entry of blood vessels
and nerves into the usually avascular and aneural inner
AF [43,45,55-57]. IL-1β, IL-6, IL-8 and TNFα are potent
inflammatory mediators present within disc degeneration
[12,13,15,17,18,35,41,58] and, as shown in this study, cyto-
kines are able to mediate factors involved in innervation,
pain transmission and angiogenesis; this confirms regula-
tion of NGF and BDNF seen previously following cytokine
treatments of IVD cells [26,30,32,34,59]. This research
demonstrates the potential relationships between human
NP cells, nerves and blood vessels at the mRNA level and
how cytokines may mediate their ingrowth. The regulation
of these factors by cytokines also agrees with previous re-
search by Lee and colleagues [34], which showed positive
correlations between IL-1β expression in human IVD tis-
sues and that of VEGF, NGF and BDNF protein expression.
The current study identified high levels of SP at mRNA
level within human NP cells, which is significantly upregu-
lated by IL-1β stimulation in vitro. In contrast, Purmessur
and colleagues found SP expression from NP cells was sig-
nificantly downregulated by 10 ng/ml IL-1β and signifi-
cantly upregulated by TNFα [30]. To further confirm the
upregulation of SP by IL-1β in this study, conditioned
medium collected from alginate bead cultures stimulated
with IL-1β was investigated for SP protein expression.
IL-1β was shown to increase SP levels to 400 pg/ml,
suggesting IL-1β is able to actively regulate the release
of SP from NP cells.
The production of SP within other cell types has dem-
onstrated dose-dependent increases in the secretion of
proinflammatory cytokines via the activation of mitogen-
activated protein kinases (p38 and c-jun N terminal kin-
ase), and nuclear factor kappa beta (NFκβ). IL-1β, IL-6,
IL-8 and TNFα are known targets of the NFκβ signalling
pathway [60,61], which is involved in the production of
ADAMTS-4 and ADAMTS-5 [62]. The release of SP
from NP cells into the matrix could thus potentially up-
regulate production of proinflammatory cytokines via
activation of the NFκβ pathway. NP cells producing in-
flammatory cytokines may cause an indirect effect on
nerves and blood vessels that are known to express SP
receptor neurokinin-1 [63] via the production and up-
regulation of SP, which could act in an autocrine/para-
crine manner within the degenerate IVD, intensifying
the targeted destruction of extracellular matrix as well as
sensitisation of ingrowing nerves.
Interestingly, neither nerve cells nor endothelial cells
stimulated with cytokines displayed regulation of neuro-
trophic or angiogenic factor expression, which was in stark
contrast to the responses seen within stimulated NP cells.
The lack of response seen in these cell types could repre-
sent the lack of regulation of neurotrophic and angiogenic
factors by native blood vessels and of nerve fibres that
ingrow into the disc by cytokines. However, the clear
regulation of neurotrophic and angiogenic factors by cyto-
kines, particularly IL-1β, suggest these factors play a major
role in the neurotrophic and angiogenic factor expression
within degenerate discs that contain a rich source of cyto-
kines. This increase in neurotrophic factors by degenerate
discs, confirmed by the number of discs containing these
factors in degeneration, suggests they play a major role in
the regulation of nerve and blood vessel ingrowth in the de-
generate disc. To date, few studies have investigated the
production of neurotrophic factor expression by SH-SY5Y
cells in response to cytokines. Moon and colleagues investi-
gated cytokine stimulation of SH-SY5Y cells co-cultured
with AF cells; they demonstrated increased production of
NGF in cytokine-treated co-cultures but not in SH-SY5Y
cells alone [59], which agrees with the results of this study.
Their results suggest either that co-culture with AF cells re-
sulted in co-stimulation of NGF expression by the SH-
SY5Y cells or that the increased production of NGF was
produced by the AF cells rather than the SH-SY5Y cells
[59], as seen in the current study with NP cells. This is the
first study to date that has investigated the induction by cy-
tokines of neurotrophic factor expression by endothelial
cells. Whilst we showed these cells expressed neurotrophic
factors CGRP and VEGF, which confirms the results of pre-
vious studies [6,64], they were not regulated by the cyto-
kines investigated within this study. A recent study by
Moon and colleagues demonstrated that microvascular
endothelial cells cultured in AF conditioned media dis-
played an increase in NGF protein production, and they
suggested IL-8 or VEGF as the secreted factors involved in
activation [65]. However, the results from this current study
demonstrated that IL-8 had no effect on endothelial cells,
suggesting VEGF may be the key player.
Conclusions
The release of cytokines, particularly IL-1β, during IVD
degeneration induced significant increases of NGF at
the mRNA level, which is hypothesised to promote neur-
onal proliferation, migration and survival within the de-
generate disc. Not only does IL-1β significantly increase
neurotrophic factors but angiogenic growth factor VEGF
was also significantly upregulated by IL-1β stimulation,
which would potentiate the ingrowth of endothelial cells
known to express NGF, which further promotes innerv-
ation. Endothelial cell expression of neurotrophic factors
was not regulated by cytokine treatment, suggesting that
cytokines affect expression of these factors within NP
cells more than nerves and blood vessels, leading to the
hypothesis that NP cells could facilitate the destruction
of the IVD by increasing their expression of NGF and
VEGF in response to IL-1β and potentially other cyto-
kines, targeting neurons and endothelial cells that are
known to express their receptors. SP that is released into
the matrix could potentially upregulate the production
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of matrix-degrading enzymes and also sensitise nerves,
resulting in nociceptive transmission and chronic low
back pain. The current study suggests IL-1β as the key
regulatory cytokine involved in the upregulation of fac-
tors involved in innervation and vascularisation of
tissues, whereas IL-6 and TNFα did not have any signifi-
cant effects on neurotrophic regulation in NP cells in
this study. These data are derived from in vitro studies
and to date the specific concentrations of these cyto-
kines has not been determined in vivo, however, so it
must be considered that other cytokines which could be
expressed at high levels in the disc may also play a role.
The majority of the cytokine-mediated responses were
in disc cells, whilst nerve and endothelial cells show min-
imal effects. NP cells could potentially regulate endothelial
cell ingrowth into the degenerate IVD via the activation of
various pathways involved in the increase of catabolic fac-
tors and upregulation of peptides known to sensitise
nerves, ultimately leading to chronic low back pain within
IVD degeneration.
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